Long term antithrombotic therapy in high risk PCI: Consider low-dose rivaroxaban with SAPT

Presenter: Giuseppe Tarantini

REGISTER for free or LOG IN to view this content

Long term antithrombotic therapy in high risk PCI: Consider low-dose rivaroxaban with SAPT

We Recommend